Back to results
US 10,118,967 B2Granted
Methods for treating rheumatoid arthritis by administering IL-6 receptor antibodies
AssigneeAblynx N.V.
InventorsSven Hoefman, Maria Laura Sargentini-Maier, Katrien Van Beneden
Life of this patent
Estimating the term…
Abstract
Methods are provided for the treatment of IL-6R related diseases. More specifically, specific dose regimens and pre-filled syringes are provided for subcutaneous administration, to subjects suffering an IL-6R related disease, of immunoglobulin single variable domains that bind IL-6R.
Claims13
A method for the treatment of rheumatoid arthritis in a human subject, said method comprising administering, to a human subject suffering from the rheumatoid arthritis, a polypeptide consisting of the amino acid sequence of SEQ ID NO:
- 34, wherein the polypeptide is administered subcutaneously at a dose of 75-300 mg every week to every two weeks.
Dependencies are inferred from the claim text.